In Flux et al.’s study, decreased CD4+/CD8+ and Foxp3+/CD8+ ratios correlated with a more favorable outcome in cases of gallbladder cancer, especially those with advanced disease [30]. The gene discussed is FOXP3; the disease is gallbladder cancer.